KENILWORTH, N.J. & WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Schering-Plough has been notified that Johnson & Johnson, as a result of the proposed merger between Schering-Plough and Merck, has initiated arbitration proceedings to resolve the parties’ dispute over whether Johnson & Johnson can terminate the distribution agreement relating to Schering-Plough’s rights to REMICADE and SIMPONI.
